Radius Health Divests RAD 140 Program to Ellipses Pharma

    NEXT STORY
    electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England
    PREV STORY
    Ziopharm Oncology to Participate in Jefferies Cell Therapy Virtual Summit on October 5, 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Profound Medical Announces Second Quarter 2018 Financial Results

    TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or ...

    author_avatar
    NASDAQ Market News

    Horizon Pharma plc to Participate in Investor Conferences in November

    DUBLIN, Ireland, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial

    author_avatar
    NASDAQ Market News